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Objectives. The goal of this study was to establish guidelines for 
the prognostic use of the time domain signal-averaged electrocar- 
diogram (ECG) after myocardial infarction. 
Background. Previous studies of the prognostic use of the 
signal-averaged ECG in postinfarction patients had one or more 
of the following limitations: a small study group, empiric defini- 
tion of an abnormal recording and possible bias in the selection of 
high risk groups or classification of arrhythmic events, or both. To 
correct for these limitations, a substudy was conducted in con- 
junction with the Cardiac Arrhythmia Suppression Trial (CAST). 
Methods. Ten centers recruited 1,211 patients with acute 
myocardial infarction without application of the ejection fraction 
or Holter criteria restrictions of the main CAST protocol. Several 
clinical variables, ventricular arrhythmias on the Holter record- 
ing, ejection fraction and six signal-averaged ECG variables were 
analyzed. Patients with bundle branch block were excluded from 
the analysis, and the remaining 1,158 were followed for up to 
I year after infarction. The classification of arrhythmic events was 
reviewed independently by the CAST Events Committee. 
Results. During an average (-+SD) follow-up of 10.3 _+ 3.2 
months, 45 patients had a serious arrhythmic event (nonfatal 
ventricular tachycardia or sudden cardiac arrhythmic death). A 
Cox regression analysis with only the six signal-averaged ECG 
variables indicated that the filtered QRS duration at 40 Hz 
>120 ms (QRSD-40 Hz) at a cutpoint >120 ms was the most 
predictive criterion of arrhythmic events. In a regression analysis 
that included all clinical, Holter and ejection fraction variables, a 
QRSD-40 Hz _> 120 ms was the most significant predictor (p < 
0.0001). The positive, negative and total predictive accuracy and 
odds ratio for QRSD-40 Hz >120 ms were 17%, 98%, 88% and 8.4, 
respectively, and improved to 32%, 97%, 94% and 16.7, respec- 
tively, after combination with ejection fraction <40% and complex 
ventricular arrhythmias on the Holter recording. 
Conclusions. The signal-averaged ECG predicts serious ar- 
rhythmic events in the first year after infarction better than do 
clinical, ejection fraction and ventricular arrhythmia variables, and 
QRSD-40 Hz >120 ms provides the best predictive criterion in this 
clinical setting. 
(JAm Coil Cardio11995;25:908-14) 
In the past few years a number of studies have shown that the 
signal-averaged lectrocardiogram (ECG) can stratify patients 
recovering from acute myocardial infarction into high and low 
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risk groups for late serious arrhythmic events (defined as 
nonfatal ventricular tachycardia or sudden cardiac arrhythmic 
death) (1-4). However, these studies had a number of limita- 
tions: 1) The definition of abnormal signal-averaged ECG 
results was either determined empirically or was derived from 
relatively small study groups. 2) The investigators classified 
unwitnessed eath as due to cardiac arrhythmia without an 
independent review process. This difficulty with the classifica- 
tion of unwitnessed death (5) may have subjected those studies 
to a certain degree of bias. 3) The incidence of serious 
arrhythmic events in the first year after infarction in some of 
the studies (as high as 14% [2]) is significantly higher than the 
current incidence. Thus, previous tudy groups may not repre- 
sent the current postinfarction population. To correct for these 
limitations and to establish guidelines for the prognostic use of 
the time domain signal-averaged ECG after myocardial infarc- 
(01995 by the American College of Cardiology 0735-1097/95/$9.50 
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tion, a substudy was conducted prospectively in conjunction 
with the Cardiac Arrhythmia Suppression Trial (CAST) (6). A 
large study group was recruited from 10 of the 27 CAST 
centers, and the classification of arrhythmic death was re- 
viewed independently b the CAST Events Committee. To 
obtain a study group representative of the general population 
with acute myocardial infarction, patients were recruited with- 
out application of the ejection fraction and arrhythmia restric- 
tions of the main CAST protocol. 
Methods  
Patients. When the study was designed as a CAST sub- 
study, it was agreed that participating CAST centers would 
attempt to recruit all available patients who were screened and 
found to have a CAST-qualifying acute myocardial infarction 
(6). This was done before those patients were screened further 
to ascertain whether they would qualify for CAST according to 
specific Holter and ejection fraction criteria. Patients who later 
qualified for CAST were randomized according to CAST 
protocol and were followed up in the present study. Those 
patients represented 15% of the study sample. They also 
represented a majority but not necessarily all of the patients 
who received antiarrhythmic drugs. It was thought hat this 
design would provide a study group representative of the 
general postinfarction population. 
Patients were enrolled between days 5 and 30 after infarc- 
tion. Patients were excluded from the study if they were >79 
years old, had cardiogcnic shock, advanced cancer or renal 
disease or were unable to participate in the protocol. The 
following clinical profile was collected for each patient: age, 
gender, site of myocardial infarction, peak creatine kinase-MB 
(CK-MB) isoenzyme concentrations, u e of antiarrhythmic or 
beta-adrenergic blocking agents, history of congestive heart 
failure, history of diabetes, previous myocardial infarction and 
previous coronary artery revascularization procedures (coro- 
nary artery bypass grafting or coronary artery angioplasty). An 
attempt was made to obtain left ventricular ejection fraction 
measurements for all patients, as defined by CAST protocol 
(6). 
Signal-averaged ECG and Holter recordings. A signal- 
averaged ECG was obtained 5 to 30 days after the qualifying 
myocardial infarction while the patient was not receiving 
antiarrhythmic drugs. The signal-averaged ECG was recorded 
with either the Arrhythmia Research Technology model 1200 
EPX or Corazonix Predictor Unit. These two units were 
chosen because they use similar algorithms for defining the end 
of the QRS complex, and previous studies have shown that 
they provide comparable r sults (7). The signal-averaged ECG 
was recorded with standard bipolar orthogonal X, Y and Z 
leads. Signal averaging of ->300 beats was performed to 
achieve a diastolic noise level <I tzV. A noise level <0.5/~V 
was desirable but not required. Six signal-averaged ECG time 
domain variables were obtained: the filtered QRS duration, 
root-mean-square voltage in the last 40 ms and duration of late 
potentials of -<40-/~V amplitude recorded at both 25 to 250 
and 40 Hz bandpass filter settings. A 24-h Holter recording was 
obtained in accordance with CAST protocol (6), within 48 h of 
the baseline signal-averaged ECG. The signal-averaged ECG 
records and Holter tapes were retained by the local center. 
Subsequent review and analysis of a random sample of these 
records were conducted by the CAST Quality Assurance 
Committee. 
Follow-up and study end points. All patients were followed 
for up to 1 year after the qualifying myocardial infarction. 
Follow-up information with regard to clinical events, anti- 
arrhythmic agents or beta-blockers and coronary artery revas- 
cularization procedures was obtained at 4 and 12 months after 
baseline either by telephone or during a clinic visit. The 
primary end point events were sustained ventricular tachycar- 
dia (->120 beats/rain lasting ->30 s), arrhythmic cardiac arrest 
with resuscitation or arrhythmic death as defined in CAST (8). 
The classification ofprimary end points was reviewed indepen- 
dently by the CAST Events Committee. In addition to the 
primary end points of serious arrhythmic events, secondary end 
points of nonarrhythmic cardiac death and total mortality were 
also considered. 
Statistical analysis. The aim of the analysis was to deter- 
mine time domain signal-averaged ECG criteria that predict 
serious arrhythmic events during the first year after infarction. 
All exposure times were censored at ---365 days. Because of the 
unreliability of time domain signal-averaged ECG criteria in 
the presence of bundle branch block (9), patients with either 
right or left bundle branch block as defined by CAST ECG 
criteria (6) were excluded from analysis. Survival analyses were 
conducted using a Cox proportional hazards regression model 
(10). Separate analyses were conducted for arrhythmic and 
nonarrhythmic death. The following variables were entered 
into the model: age, gender, site of myocardial infarction, peak 
CK-MB isoenzyme concentration, QRS duration in the 12-lead 
ECG, history of congestive heart failure, history of diabetes, 
previous myocardial infarction, previous antiarrhythmic or
beta-blocker therapy, left ventricular ejection fraction, fre- 
quency of ventricular premature depolarizations and presence 
or absence of ventricular tachycardia runs (defined as ->3 
consecutive ventricular beats at a rate of ->120 beats/rain) on 
the baseline Holter recording. The six signal-averaged ECG 
variables, as continuous variables, were then allowed to enter 
stepwise. 
After determining that signal-averaged ECG variables were 
predictive of arrhythmic events, the most predictive continuous 
signal-averaged ECG variable was determined using Cox re- 
gression without controlling for baseline characteristics. Di- 
chotomous variables were then created from the most predic- 
tive measure to find the "best" cutoff. "Best" was determined 
by the highest chi-square value to enter the model. One-year 
survival was estimated by Kaplan-Meier survival on the basis of 
the two groups created by discriminating signal-averaged ECG 
criteria (11). 
Baseline characteristics of patients with arrhythmic events 
were compared with those of patients without arrhythmic 
events. Baseline characteristics of patients with abnormal 
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signal-averaged ECG results, as determined by the Cox regres- 
sions, were compared with those with normal signal-averaged 
ECG results. 
The predictive value of abnormal signal-averaged ECG 
results was compared with two other commonly utilized pre- 
dictive criteria: low left ventricular ejection fraction (dichoto- 
mized at ->40%, ->35% and ->30%) and complex ventricular 
arrhythmia on Holter recording (defined as ->10 ventricular 
premature depolarizations/h or any vcntricular tachycardia 
run, or both). For various combinations of these criteria, the 
sensitivity, specificity, predictive accuracy (percent correctly 
predicted), positive predictive accuracy (percent of "abnor- 
mal" results associated with events), negative predictive accu- 
racy (percent of "normal" results not associated with events) 
and odds ratio were determined (12). 
Resu l ts  
Arrhythmic events. During the enrollment period for the 
study, the 10 CAST participating centers had a total of 1,839 
patients with a CAST-qualifying infarction, 1,211 of whom 
were recruited into the study. Of these 1,211 patients, 52 had 
either right or left bundle branch block and were excluded 
from further analysis. One patient had no follow-up and was 
also excluded. The remaining 1,158 patients were followed up 
for an average (_+SD) of 10.3 _+ 3.2 months (range 0 to 12, 
median 11.7). Fifteen patients died of noncardiac-related 
causes, and 29 died of cardiac-related causes judged not to be 
due to cardiac arrhythmia. Forty-five patients had a serious 
arrhythmic event (an incidence of 4.3% for the first year after 
infarction). Three patients had symptomatic nonfatal sustained 
ventricular tachycardia. In 42 patients death was judged to be 
due to arrhythmia. Eleven of the 42 arrhythmic deaths oc- 
curred in-hospital or in the emergency room, and 28 occurred 
out-of-hospital. A record of the final cardiac rhythm was 
available for 21 of the 42 patients. Ventricular tachycardia/ 
ventricular fibrillation was documented in 15 patients and 
asystole in 5. One patient had an "unknown" rhythm. Four of 
the patients with asystole as a final cardiac rhythm had 
experienced out-of-hospital cardiac arrest. Thirty-six percent 
of the arrhythmic events occurred in the first 2 months and 
67% in the first 6 months after myocardial infarction. 
Clinical profile and signal-averaged ECG in patients with 
and without an arrhythmie event. Table 1 summarizes the 
clinical profile and signal-averaged ECG characteristics of 
patients with and without an arrhythmic event. There was no 
difference in age, gender, peak CK-MB isoenzyme concentra- 
tions or revascularization procedures between patients with 
and without an arrhythmic event. The incidence of combined 
anterior and inferior wall myocardial infarction and non-Q 
infarction, congestive heart failure, diabetes and previous 
infarction were significantly higher in patients with an arrhyth- 
mic event. Less than 4% of all patients received antiarrhythmic 
therapy. Although patients with an arrhythmic event received 
statistically more antiarrhythmic therapy than patients without 
a serious arrhythmic event, only 5 of the 45 patients with a 
Table 1. Clinical Profile and Signal-Averaged Electrocardiographic 




(n - 45) (n = 1,113) p Value 
Mean age (yr) 63.1 60.1 0.068 
% Male 75.6 72.3 0.760 
Ant MI (%) 25.0 22.2 0.797 
lnf MI (%) 36.4 31.1 0.569 
Ant+lnf MI (%) 22.7 8.6 0.003 
Non-Q wave MI (%) 15.6 37.2 0.005 
Peak CK-MB (IU/liter) 10.5 12.1 0.116 
Antiarrhythmic agents (%) 11.1 3.0 0.010 
Beta-blockers (%) 17.8 38.5 0.008 
Revascularization procedure I3.3 19.4 0.411 
since baseline 
History of 
CHF (%) 25.0 6.8 0.0000 
Diabetes (%) 42.2 20.0 0.001 
MI (%) 48.9 21.7 0.0000 
Ejection fraction (%) 33.6 47.4 0.0000 
VA on Holter (%) 60.0 28.9 0.0000 
QRSD/ECG (ms) 98.7 91.1 0.0004 
QRSD/25 Hz (ms) 119.0 104.2 0.0001 
RMS-40/25 Hz (p-V) 42.7 60.6 0.030 
LPD/25 Hz (ms) 38.8 28.4 0.006 
QRSD/40 Hz (ms) 115.2 101.4 0.0000 
RMS-40/40 Hz (p.V) 29.4 38.7 0.060 
LPD/40 Hz (ms) 40.1 32.9 0.017 
Signal-averaged lectrocardiographic (ECG) variables were recorded at 25 
and 40 Hz high bandpass filter settings, respectively. Ant - anterior; CHF = 
congestive heart failure; CK-MB = creatine kinase-MB isoenzyme; Inf 
inferior; LPD late potential duration -<40 ~V; MI - myocardial infarction; 
QRSD - duration of filtered QRS complex; QRS/ECG - QRS duration on the 
12-lead ECG; RMS-40 - root-mean-square voltage of signals in the last 40 ms; 
VA - complex ventricular arrhythmias. 
serious arrhythmic event received antiarrhythmic therapy. The 
incidence of complex ventricular arrhythmia on the baseline 
Holter recording was higher, left ventricular ejection fraction 
significantly lower and QRS duration on the 12-lead ECG 
significantly longer in patients with an arrhythmic event. The 
filtered QRS duration of the signal-averaged ECG and dura- 
tion of late potentials were significantly onger in patients with 
an arrhythmic event at both 25 and 40 Ha. However, although 
the root-mean-square voltage of the signals in the last 40 ms 
was lower in patients with an arrhythmic event, this difference 
reached statistical significance only at 25 Ha. Using the Cox 
proportional hazards regression model to control for clinical 
variables that showed a significant difference between patients 
with and without an arrhythmic event, the signal-averaged 
ECG variables were found to be independently predictive of an 
arrhythmic event (p < 0.011). However, the signal-averaged 
ECG variables did not predict nonarrhythmic death after 
controlling for other baseline variables. 
Definition of the best prediction criteria of the signal. 
averaged ECG. Having determined that the signal-averaged 
ECG variables were independently predictive of arrhythmic 
events, we found that the most predictive continuous variable 
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Table 2. Predictive Values of Continuous Signal-Averaged 
Electrocardiographic Variables and Best Cutoff or 
QRSD/40 Hz (ms) 
Chi-Square 
Value p Value 
Variable 
QRSD/25 Hz 30.08 0.0000 
RMS-40/25 Hz 4.68 0.0305 
LPD/25 Hz 21.91 0.0000 
QRSD/40 Hz* 34.46 0.0000 
RMS-40/40 Hz 3.63 0.0568 
kPD/40 Hz 12.95 0.0003 
Cutpoint 
100 13.49 0.0002 
110 31.19 0.0000 
112 33.41 0.00(X) 
114 39.27 0.0000 
116 41.26 0.0000 
118 44.80 0.0000 
120" 54.89 0.0000 
122 54.56 0.0000 
124 40.86 0.00(!0 
126 32.38 0.0(/0(I 
128 20.71 0.0000 
130 18.91 0.0000 
140 3.31 0.0687 
*Variable with highest chi-square value. Abbreviations as in Table 1. 
could be determined by the Cox regression without correcting 
for baseline characteristics. The filtered QRS duration at 
40 Hz was the most predictive, with the highest chi-square 
value of 34.46 (Table 2). To determine the best cutoff value for 
the filtered QRS duration at 40 Hz, dichotomous variables 
were created. A filtered QRS duration ->120 ms had the 
highest chi-square value and thus provided the best predictive 
criterion (Table 2). The combination offiltered QRS duration 
at 40 Hz ->120 ms with other dichotomized signal-averaged 
ECG variables did not improve the predictive value of the test. 
Thus, abnormal signal-averaged ECG results were defined as a 
filtered QRS duration at 40 Hz ->120 ms. The incidence of 
abnormal signal-averaged ECG results in this group of postin- 
farction patients was 12%. In a regression analysis including all 
clinical, Holter and left ventricular ejection fraction variables, 
the filtered QRS duration at 40 Hz ->120 ms was the most 
significant predictor of an arrhythmic event (p < 0.0001). 
Table 3 compares the clinical profile of patients with normal 
and abnormal signal-averaged ECG results. Figure 1 shows 
that the probability of remaining free of a serious arrhythmic 
event during the first year after infarction was significantly 
higher in patients with normal (98%) than abnormal (81%) 
signal-averaged ECG results (p < 0.000l). 
Prognostic significance of signal-averaged ECG, left ven- 
tricular ejection fraction and complex ventricular arrhythmias 
for an arrhythmic event. Table 4 shows the sensitivity, speci- 
ficity, total predictive accuracy, positive and negative predictive 
accuracy, chi-square value and odds ratio for the signal- 
averaged ECG, left ventricular ejection fraction, complex 
Table 3. Clinical Profile of Patients With Normal and Abnormal 




(n = 138) (n - 1,024) p Value 
Mean age (yr) 61.4 60.1 0.195 
% Male 71.4 80.6 0.032 
Ant MI (%) 16.8 23.0 0.134 
Inf MI (%) 38.2 30.4 0.089 
Ant+Inf MI (%) 11.5 8.8 0.412 
Non-Q wave MI (%) 32.8 36.8 0.422 
Peak CK-MB (IU/liter) 12.0 12.1 0.928 
Antiarrhythmic agents (%) 8.2 2.6 0.002 
Beta-blockers (%) 29.9 38.8 0.056 
Revascularization procedure 15.7 19.6 0.328 
since baseline (%) 
History of 
CHF (%) 21.1 5.8 0.0000 
Diabetes (%) 30.6 19.6 0.005 
MI (%) 42.5 20.2 0.0000 
Ejection fraction (%) 38.1 48.1 0.0000 
VA on Holter (%) 50.7 27.4 0.0000 
QRSD/ECG (ms) 105.4 89.4 0.0000 
QRSD/25 Hz (ms) 135.1 100.8 0.0000 
RMS-40/25 Hz (/zV) 24.8 64.4 0.0000 
LPD/25 Hz (ms) 42.9 26.9 0.0000 
QRSD/40 Hz (ms) 133.9 97.7 NA 
RMS-40/40 Hz (IxV) 15.0 41.4 0.0000 
LPD/40 Hz (ms) 51.0 30.8 0.0000 
Abnormal SAECG Results = duration of filtered QRS complex (QRSD) at 
40 Hz ->120 ms on the signal-averaged electrocardiogram (SAECG); other 
abbreviations as in Table 1. 
ventricular arrhythmia on the baseline Holter recording and 
various combinations of the three tests for prediction of an 
arrhythmic event in the first year after infarction. Left ventric- 
ular ejection fraction is shown dichotomized at <40%. We 
compared the predictive accuracy of left ventricular ejection 
fraction dichotomized at -<40%, -<35% and -<30%. The best 
values were obtained at -<40%. This could possibly be related 
to the relatively small number of patients in the lower ejection 
fraction group. Mean left ventricular ejection fraction in 
patients without an arrbythmic event, who comprised >95% of 
the study group, was 47.4%. Table 4 shows that the negative 
predictive accuracy of all three tests was high (98%). However, 
both positive (17%) and total (88%) predictive accuracy of the 
signal-averaged ECG were significantly higher than those of 
ejection fraction alone and complex ventricular arrhythmias 
alone and remained slightly higher than the combination of 
both tests. Combining either ejection fraction -<40% or com- 
plex ventricular arrhythmias with abnormal signal-averaged 
ECG results improved positive and total predictive accuracy 
significantly. The best positive predictive accuracy of 32% was 
obtained by a combination of a filtered QRS ->120 ms, left 
ventricular ejection fraction -<40% and complex ventricular 
arrhythmias on the baseline Holter recording. However, only a 
small fraction of all patients with acute myocardial infarction 
912 EL-SHERIF ET AL. JACC Vol. 25, No. 4 
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85 QRSD / 40 Hz < 120 ms 
816 QRSD / 40 Hz >= 120 ms 
Figure 1. Probability of remaining free of ar- 
rhythmic events in patients with filtered QRS 
duration at 40 Hz (QRSD/40 Hz) <120 ms 
(normal signal-averaged lectrocardiographic 
[ECG] results) and ->120 ms (abnormal signal- 
averaged ECG results). 
had abnormal results on all three tests (34 [4.1%] of 826). 
However, in addition to abnormal results on these tests, a 
number of clinical high risk variables (e.g., incidence of 
zongestive heart failure and history of previous infarction) 
were also higher among patients with an arrhytbmic event. 
Discussion 
Incidence of serious arrhythmic events in the first year 
after infarction. In the present study the calculated total 
mortality rate for the first year after infarction was 8.0% (1.3% 
for noncardiac death, 2.7% for cardiac nonarrhythmic death 
and 4.0% for cardiac arrhythmic death). The incidence of 
sudden cardiac "arrhythmic" death in the present study of 
4.0% is remarkably similar to that for sudden death of 3.6% at 
12 months reported previously by Surawicz (13). However, the 
incidence of nonfatal sustained ventricular tachycardia in the 
present study was very low (0.3% in the first year after 
Table 4. Relation of Signal-Averaged Electrocardiogram, Left 
Ventricular Ejection Fraction and Complex Ventricular Arrhythmias 
on Holter Recording to Arrhythmic Events 
Sens Spec TPA PPA NPA 
Risk (%) (%) (%) (%) (%) Chi OR 
SAECG 48 90 88 17 98 42 8.4 
VA 61 69 69 8 98 12 3.5 
EF 70 69 69 9 98 20 5.1 
VA+EF 58 86 85 15 98 43 8.4 
SAECG+VA+EF 33 97 94 32 97 67 16.7 
SAECG+VA 36 95 93 24 97 49 11.0 
SAECG+EF 39 95 93 25 97 57 12.2 
Chi chi-square value; EF - left ventricular ejection fraction; NPA (PPA) 
= negative (positive) predictive accuracy; OR odds ratio; SAECG - 
signal-averaged electrocardiogram; Sens - sensitivity; Spec specificity; TPA = 
total predictive accuracy; VA - complex ventricular rhythmias onHolter 
recording. 
infarction). The incidence of sustained ventricular tachycardia 
(defined by CAST as ->15 beats/rain) in both CAST I (6) and 
CAST II (14) placebo groups was also low (0.9% and 1%, 
respectively), even though the CAST population represented a 
higher risk group for arrhythmic events (15). Several studies 
that evaluated the prognostic significance of the signal- 
averaged ECG in the first year after infarction reported an 
incidence of nonfatal sustained ventricular tachycardia of 1.6% 
(16) to 7% (2). The reasons for the difference between these 
studies and the results of CAST and the present study are not 
evident. This could possibly be related to differences in patient 
selection and the bias introduced by the relatively small sample 
size in the signal-averaged studies, or it may reflect changes in 
the contemporary natural history of postinfarction patients. 
Definition of the best predictive criteria of the signal- 
averaged ECG in the postinfarction period. Two general 
approaches have been utilized to derive time domain criteria 
for abnormal time domain signal-averaged ECG results. The 
first approach investigated "normal" study groups to obtain 
"upper limits" for normal signal-averaged ECG results (17,18). 
This approach has been criticized because "normal" study 
groups are not representative of the population with coronary 
artery disease. The second approach evaluated the predictive 
value of signal-averaged ECG criteria in patients with sponta- 
neous or inducible sustained ventricular tachycardia, or both 
(19,20). In these patients, time domain signal-averaged ECG 
criteria reflecting the presence of late potentials (i.e., the 
root-mean-square voltage in the last 40 ms or the duration of 
the late potentials of -<40 txV, or both) were usually the most 
predictive. The electrophysiologic rationale for the predictive 
value of these criteria was that late potentials represent slowed 
and disorganized conduction of localized myocardial zones 
that could provide the anatomic-electrophysiologic substrate 
for reentrant ventricular tachycardia (21). It does not neces- 
sarily follow that these criteria would be also predictive in the 
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post-myocardial nfarction period, where the majority of seri- 
ous arrhythmic events are fatal ventricular tachyarrhythmias 
rather than nonfatal sustained ventricular tachycardia. In the 
present study, time domain signal-averaged ECG indexes of 
late potentials did not provide the best prediction criteria for a 
serious arrhythmic event. The signal-averaged QRS duration 
at 40 Hz high bandpass filter was found to be the single best 
predictive criterion. It should be emphasized that the signal- 
averaged QRS duration includes the low amplitude late po- 
tential signal. That is why the signal-averaged QRS duration is 
usually longer than the QRS duration measured from the 
surface 12-lead ECG (Tables 1 and 3). In the present study the 
surface ECG QRS duration lacked independent predictive 
significance. The electrophysiologic rationale as to why an 
abnormally long signal-averaged QRS duration best predicts 
fatal arrhythmic events in the first year after infarction is not 
clear. However, it is possible to speculate that a long signal- 
averaged QRS duration may reflect slowed and nonhomo- 
geneous conduction of a larger mass of ventricular myocar- 
dium. Such hearts may be more vulnerable to fast ventricular 
tachycardia/fibrillation. 
At least one previous study (22) also found that the 
duration of the signal-averaged QRS complex at 40-Hz high 
filter setting had the most significant relation to an arrhythmic 
event in the postinfarction period. However, this study (22) did 
not evaluate the best dichotomized value for the use of the 
signal-averaged QRS complex. Furthermore, the incidence of 
both sustained ventricular tachycardia (7%) and overall seri- 
ous arrhythmic events (14%) was much higher than most other 
studies, possibly reflecting the selection of a higher isk group. 
In the present study the incidence of abnormal signal- 
averaged ECG results of 12% in the postinfarction population 
was lower than previously reported rates of 31% (4) to 52% 
(23) using various different criteria. Also, the positive predic- 
tive accuracy of the signal-averaged ECG in the present study 
of 17% is lower than most of the previously reported values of 
17% (1) to 29% (2). However, the incidence of serious 
arrhythmic events in the present study of 4.3% is also lower 
than that of 7% (4) to 14% (2) reported in other studies. 
Conclusions. The signal-averaged QRS duration at 40-Hz 
high bandpass filter _>120 ms is a better predictor of serious 
arrhythmic events in the first year after infarction than a 
battery of clinical variables, complex ventricular ectopic activ- 
ity on the Holter ECG or left ventricular ejection fraction. 
Because the positive predictive accuracy of the test is still 
relatively low (17%), the most appropriate strategy for man- 
agement of postinfarction patients with abnormal signal- 
averaged ECG findings is not yet established. However, the 
combination of abnormal signal-averaged ECG results, low 
ejection fraction and complex ventricular ectopic activity on 
the Holter ECG can provide a higher positive predictive 
accuracy for a serious arrhythmic event (32%) in postinfarction 
patients. 
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